The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy

BACKGROUND: Targeted axillary dissection (TAD), the combination of sentinel lymph node biopsy (SLNB) and targeted lymph node biopsy (TLNB), can reduce the false negative rates of sentinel node biopsy alone dramatically in breast cancer patients, who received neoadjuvant chemotherapy (NAC). However m...

Descripción completa

Detalles Bibliográficos
Autores principales: Reitsamer, R., Peintinger, F., Forsthuber, E., Sir, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050798/
https://www.ncbi.nlm.nih.gov/pubmed/33813230
http://dx.doi.org/10.1016/j.breast.2021.03.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050798/
https://www.ncbi.nlm.nih.gov/pubmed/33813230
http://dx.doi.org/10.1016/j.breast.2021.03.008

Ejemplares similares